CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy [Phase 2]
Summary
Phase 2 dose-ranging trial evaluating VX-150 for acute pain after bunionectomy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Acute Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09